drugset / Trial / NCT05817890
Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
This will be a Phase 1, open-label, single dose study of the Absorption, Metabolism, and Excretion of CYC065 in healthy male subjects.
Timeline
- Start
- 2023-03-03
- Primary completion
- 2024-02-29
- Completion
- 2024-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYC065 | Small molecule | — | Oral |
Indications
No indication recorded.